| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |